Does POTASSIUM, MONOBASIC Cause Off label use? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Off label use have been filed in association with POTASSIUM, MONOBASIC (Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate). This represents 18.1% of all adverse event reports for POTASSIUM, MONOBASIC.
27
Reports of Off label use with POTASSIUM, MONOBASIC
18.1%
of all POTASSIUM, MONOBASIC reports
0
Deaths
7
Hospitalizations
How Dangerous Is Off label use From POTASSIUM, MONOBASIC?
Of the 27 reports, 7 (25.9%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POTASSIUM, MONOBASIC. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does POTASSIUM, MONOBASIC Cause?
Condition aggravated (38)
Respiratory failure (35)
Febrile neutropenia (25)
Drug hypersensitivity (21)
Toxic epidermal necrolysis (20)
Product use in unapproved indication (17)
Death (16)
Drug ineffective (14)
Macular degeneration (14)
Pyrexia (10)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which POTASSIUM, MONOBASIC Alternatives Have Lower Off label use Risk?
POTASSIUM, MONOBASIC vs POTASSIUM\SODIUM FLUORIDE
POTASSIUM, MONOBASIC vs POVIDONE-IODINE
POTASSIUM, MONOBASIC vs PRABOTULINUMTOXINA-XVFS
POTASSIUM, MONOBASIC vs PRADAXA
POTASSIUM, MONOBASIC vs PRALATREXATE